| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVET | Common Stock | Options Exercise | $0 | +24,089 | +383% | $0.000000 | 30,377 | 13 May 2021 | Direct | |
| transaction | CVET | Common Stock | Sale | $248,537 | -9,636 | -32% | $25.79 | 20,741 | 14 May 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVET | Restricted Stock Units | Options Exercise | $0 | -24,089 | -100% | $0.000000* | 0 | 13 May 2021 | Common Stock | 24,089 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Sale pursuant to 10b5-1 Plan dated March 3, 2021. |
| F2 | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.24 - $26.04. The Reporting Person hereby undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F3 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof. |
| F4 | Subject to the Reporting Person's continuous service as a director of the Issuer, 100% of the RSUs will vest on the first anniversary of the grant date. |